Effects of pre-existing type 1 diabetes mellitus on survival outcome following out-of-hospital cardiac arrest: a registry-based observational study in Sweden.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
15 Jul 2024
Historique:
medline: 16 7 2024
pubmed: 16 7 2024
entrez: 15 7 2024
Statut: epublish

Résumé

It has been estimated that 80% of cases of out-of-hospital cardiac arrest (OHCA) are due to cardiac causes. It is well-documented that diabetes is a risk factor for conditions associated with sudden cardiac arrest. Type 1 diabetes (T1D) displays a threefold to fivefold increased risk of cardiovascular disease and death compared with the general population. This study aims to assess the characteristics and survival outcomes of individuals with and without T1D who experienced an OHCA. Using the Swedish Cardiopulmonary Resuscitation Registry, we enrolled 54 568 cases of OHCA where cardiopulmonary resuscitation was attempted between 2010 and 2020. Among them, 448 patients with T1D were identified using International Classification of Diseases-code: E10. Survival analysis was performed using Kaplan-Meier and logistic regression. Multiple regression was adjusted for age, sex, cause of arrest, prevalence of T1D and time to cardiopulmonary resuscitation. The outcomes were discharge status (alive vs dead), 30 days survival and neurological outcome at discharge. There were no significant differences in patients discharged alive with T1D 37.3% versus, 46% among cases without T1D. There was also no difference in neurological outcome. Kaplan-Meier curves yielded no significant difference in long-term survival. Multiple regression showed no significant association with survival after accounting for covariates, OR 0.99 (95% CI 0.96 to 1.02), p value=0.7. Baseline characteristics indicate that patients with T1D were 5 years younger at OHCA occurrence and had proportionally fewer cases of heart disease as the cause of arrest (57.6% vs 62.7%). We conclude, with the current sample size, that there is no statistically significant difference in long-term or short-term survival between patients with and without T1D following OHCA.

Sections du résumé

BACKGROUND BACKGROUND
It has been estimated that 80% of cases of out-of-hospital cardiac arrest (OHCA) are due to cardiac causes. It is well-documented that diabetes is a risk factor for conditions associated with sudden cardiac arrest. Type 1 diabetes (T1D) displays a threefold to fivefold increased risk of cardiovascular disease and death compared with the general population.
OBJECTIVE OBJECTIVE
This study aims to assess the characteristics and survival outcomes of individuals with and without T1D who experienced an OHCA.
PARTICIPANTS METHODS
Using the Swedish Cardiopulmonary Resuscitation Registry, we enrolled 54 568 cases of OHCA where cardiopulmonary resuscitation was attempted between 2010 and 2020. Among them, 448 patients with T1D were identified using International Classification of Diseases-code: E10.
METHODS METHODS
Survival analysis was performed using Kaplan-Meier and logistic regression. Multiple regression was adjusted for age, sex, cause of arrest, prevalence of T1D and time to cardiopulmonary resuscitation.
MAIN OUTCOME MEASURES METHODS
The outcomes were discharge status (alive vs dead), 30 days survival and neurological outcome at discharge.
RESULTS RESULTS
There were no significant differences in patients discharged alive with T1D 37.3% versus, 46% among cases without T1D. There was also no difference in neurological outcome. Kaplan-Meier curves yielded no significant difference in long-term survival. Multiple regression showed no significant association with survival after accounting for covariates, OR 0.99 (95% CI 0.96 to 1.02), p value=0.7. Baseline characteristics indicate that patients with T1D were 5 years younger at OHCA occurrence and had proportionally fewer cases of heart disease as the cause of arrest (57.6% vs 62.7%).
CONCLUSION CONCLUSIONS
We conclude, with the current sample size, that there is no statistically significant difference in long-term or short-term survival between patients with and without T1D following OHCA.

Identifiants

pubmed: 39009457
pii: bmjopen-2023-080710
doi: 10.1136/bmjopen-2023-080710
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e080710

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Berkan Eken (B)

Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden berkan__eken@hotmail.com.

Araz Rawshani (A)

Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg, Sweden.

Aidin Rawshani (A)

Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg, Sweden.

Zacharias Mandalenakis (Z)

Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg, Sweden.

Erik Thunstrom (E)

Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg, Sweden.

Antros Louca (A)

Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg, Sweden.

Petur Petursson (P)

Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg, Sweden.

Oskar Angerås (O)

Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg, Sweden.

Sadek Nadhir (S)

Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Christian Dworeck (C)

Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg, Sweden.

Truls Råmunddal (T)

Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH